cenicriviroc
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Cenicriviroc (CVC) is a first-in-class dual CCR2/5 antagonist with potent anti-inflammatory and antifibrotic properties. The 1…
Background and aim The hepatitis C virus (HCV) is a single-strand RNA virus that infects millions of people worldwide. Recent…
Acute graft-versus-host disease (aGVHD) is one of the major complications after liver transplantation (LTx), which is induced by…
NAFLD is a wide spectrum disease ranging from simple steatosis, NASH to liver cirrhosis and is the most common type of CLD in the…
The search goes on for effective medical treatment of nonalcoholic steatohepatitis (NASH). The following are phase IIb trial…
ZusammenfassungDie Leberfibrose, d. h. die bindegewebige Vernarbung der Leber, stellt die gemeinsame Endstrecke chronischer…
Cenicriviroc (CVC), a once‐daily, dual CCR5/CCR2 co‐receptor antagonist, has completed Phase 2b development. CVC demonstrated…
There are 28 approved antiretroviral drugs for the treatment of HIV infection; combinations of these drugs clearly change the…